Interrupting the dark dance of briberyBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6573 (Published 12 November 2014) Cite this as: BMJ 2014;349:g6573
- Alain Braillon, senior consultant1
- 180000 Amiens, France
Dyer reported that a joint meeting of the Royal College of Physicians and The BMJ concluded that doctors should be obliged to adhere to a code of conduct on relationships with industry and to declare their interactions with drug and medical device companies on a publicly accessible searchable database.1 Was a meeting necessary? What’s next?
Little progress has …
Log in using your username and password
Log in through your institution
Sign up for a free trial